Utama › Kanser Pundi Kencing › California › Baldwin Park
Kajian klinikal Kanser Pundi Kencing di Baldwin Park, CA
14 kajian untuk Kanser Pundi Kencing sedang mencari peserta di lokasi dalam dan sekitar Baldwin Park (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Mengambil pesertaFasa 1
- City of Hope National Medical Center, Duarte · 4 mi jauh
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Mengambil pesertaFasa 2
- City of Hope - Duarte Cancer Center, Duarte · 4 mi jauh
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 2
- City of Hope, Duarte · 4 mi jauh
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Mengambil pesertaFasa 1
- City of Hope National Medical Center, Duarte · 4 mi jauh
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Mengambil pesertaFasa 2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauh
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Mengambil pesertaFasa 1/2
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 4 mi jauh
- City of Hope Investigational Drug Services (IDS), Duarte · 4 mi jauh
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Mengambil pesertaFasa 1
- City of Hope Cancer Center-Duarte, Duarte · 4 mi jauh
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Mengambil pesertaFasa 1
- City of Hope, Duarte · 4 mi jauh
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Mengambil pesertaFasa 1
- City of Hope, Duarte · 4 mi jauh
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Mengambil pesertaFasa 2
- Kaiser Permanente Baldwin Park Medical Center, Baldwin Park
Telehealth Intervention for Ostomy Self-Management
Mengambil pesertaFasa 2
- City of hope Medical Center, Duarte · 4 mi jauh
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- City of Hope, Duarte · 4 mi jauh
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
Mengambil peserta
- City of Hope Medical Center, Duarte · 4 mi jauh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Duarte · 4 mi jauh
Kajian Kanser Pundi Kencing di bandar lain
- New York City, NY35 kajian
- Nashville, TN31 kajian
- Houston, TX31 kajian
- Dallas, TX27 kajian
- Boston, MA26 kajian
- Washington, DC26 kajian
- Los Angeles, CA24 kajian
- Baltimore, MD24 kajian
- St. Louis, MO22 kajian
- Philadelphia, PA21 kajian
- Seattle, WA21 kajian
- Edison, NJ21 kajian
Kajian lain di Baldwin Park
- Kanser Payudara45 kajian
- Leukemia Mieloid Akut40 kajian
- Kanser Kolorektal38 kajian
- Kanser Paru-paru Bukan Sel Kecil36 kajian
- Kanser (semua jenis)33 kajian
- Kanser Prostat30 kajian
- Kanser Metastatik30 kajian
- Sindrom Mielodisplastik26 kajian
- Kanser Ovari25 kajian
- Kanser Paru-paru24 kajian
- Mieloma Pelbagai23 kajian
- Kanser Perut22 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.